06/01/2026
It makes sense that synthetic cannabinoids demonstrated the most shrinkage in certain cancers. They tend to be more potent and attach to receptors more tightly and for longer periods of time than botanical cannabinoids. In addition, their metabolites can behave similarly.
This is one reason why using them in prenatal cannabis exposure research can lead to bad outcomes.
Components of ma*****na show “consistent and statistically significant anti-tumor effects” in certain types of cancer, including glioblastoma and breast cancer, according to a new scientific review that also found cannabinoids seem to “enhance chemotherapy efficacy.” The research, published ...